HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Oct. 31, 2017 (HealthDay News) -- Rates of systemic lupus erythematosus (SLE) mortality have decreased since 1968 but are still higher than non-SLE mortality, according to a study published online Oct. 30 in the Annals of Internal Medicine.
Eric Y. Yen, M.D., from the University of California, Los Angeles, and colleagues identified secular trends and population characteristics associated with SLE mortality using a national mortality database and census data. Annual age-standardized mortality rates (ASMRs) were analyzed for SLE and non-SLE causes.
From 1968 through 2013, the researchers identified 50,249 SLE deaths and 100,851,288 non-SLE deaths. The SLE ASMR decreased less than the non-SLE ASMR over this period, with a 34.6 percent cumulative increase in the ratio of the former to the latter. There was a decrease in the non-SLE ASMR every year starting in 1968, while the SLE ASMR decreased from 1968 to 1975, increased from 1975 to 1999, and decreased from 2000 onward. Over the 46-year period, there were no statistically significant increases in the SLE ASMR among whites. Females, blacks, and residents of the South had higher SLE ASMRs and larger cumulative increases in the ratio of SLE to non-SLE ASMR than males, other racial/ethnic groups, and residents of other regions (31.4, 62.5, and 58.6 percent, respectively).
"Rates of SLE mortality have decreased since 1968 but remain high relative to non-SLE mortality, and significant sex, racial, and regional disparities persist," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 29, 2022